Ionis Pharmaceuticals
IONS
$41.80
Share price
-0.10%
Change (1 day)
16.50%
Change (1 year)
Categories
P/S ratio for Ionis Pharmaceuticals (IONS)
P/S ratio as of April 2024 (TTM): 7.78
According to Ionis Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.77569. At the end of 2023 the company had a P/S ratio of 9.22.
P/S ratio history for Ionis Pharmaceuticals from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 9.22 | 0.88% |
| 2022 | 9.13 | 72.28% |
| 2021 | 5.30 | -51.09% |
| 2020 | 10.8 | 43.54% |
| 2019 | 7.55 | -39.26% |
| 2018 | 12.4 | 2.74% |
| 2017 | 12.1 | -27.64% |
| 2016 | 16.7 | -36.34% |
| 2015 | 26.3 | -23.06% |
| 2014 | 34.1 | 8.38% |
| 2013 | 31.5 | 203.46% |
| 2012 | 10.4 | 43.06% |
| 2011 | 7.26 | -21.74% |
| 2010 | 9.27 | 2.67% |
| 2009 | 9.03 | -35.52% |
| 2008 | 14.0 | -29.03% |
| 2007 | 19.7 | -47.09% |
| 2006 | 37.3 | 295.66% |
| 2005 | 9.43 | 18.55% |
| 2004 | 7.95 | 10.07% |
| 2003 | 7.22 | 59.18% |
| 2002 | 4.54 | -79.73% |
| 2001 | 22.4 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
 NRC Health
NRC | 5.42 | -30.31% | 🇺🇸 USA |